Author

T. Pankotai

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Cell Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Research Focus:cell type annotation· 2 Research Focus:chromatin & epigenetic regulation· 2 Approach:experimental assay· 2 Assay:imaging· 2 Assay:proteomics· 2 Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1

Frequent Co-Authors

Z. Ujfaludi· 3 shared B. N. Borsos· 2 shared H. Majoros· 2 shared A. A. Ascsillan· 1 shared A. Bartha· 1 shared A. Csokasi· 1 shared A. Dobi· 1 shared A. Nikolenyi· 1 shared

Activity by Year

2019-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

Z. Ujfaludi

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Identifying Ferroptosis Inducers, HDAC, and RTK Inhibitor Sensitivity in Melanoma Subtypes through Unbiased Drug Target Prediction

I. Pla, B. L. Szabolcs, P. N. Peter, Z. Ujfaludi, Y. Kim, P. Horvatovich, A. Sanchez, K. Pawlowski, E. Wieslander, J. Guedes, D. M. Pal, A. A. Ascsillan, L. H. Betancourt, I. B. Nemeth, J. Gil, , L. V. Kemeny

This paper identifies potential drug targets and predicts treatment efficacy and resistance in melanoma subtypes using proteogenomic data and drug sensitivity analysis.

bioRxiv · Feb 8, 2024 · PreprintCancer Biology

Cytoplasmic Aggregation of RPB1 Predicts Failure of Neoadjuvant Chemotherapy

B. Nagy-Miko, O. Nemeth-Szatmari, R. Farago-Meszaros, A. Csokasi, B. Bognar, N. Ördög, B. N. Borsos, H. Majoros, Z. Ujfaludi, O. Olah-Nemeth, A. Nikolenyi, A. Dobi, R. Koszo, D. Santha, G. Lazar, , A. Vörös

The paper shows that cytoplasmic RPB1 aggregation in biopsy samples predicts poor response to neoadjuvant chemotherapy in invasive carcinoma patients.

bioRxiv · Jan 13, 2023 · PreprintCancer Biology

Epilepsy kinase CDKL5 is a DNA damage sensor which controls transcriptional activity at DNA breaks

T. Khanam, I. Munoz, F. Weiland, T. Carroll, B. N. Borsos, V. Pantazi, M. Slean, M. Novak, R. Toth, P. Appleton, T. Pankotai, H. Zhou, J. Rouse

CDKL5 is a DNA damage-sensing kinase that modulates transcriptional activity near DNA breaks.

bioRxiv · Dec 10, 2020 · PreprintCell Biology

Quantification of DNA damage induced γH2AX focus formation via super-resolution dSTORM localization microscopy

D. Varga, H. Majoros, Z. Ujfaludi, M. Erdelyi, T. Pankotai

This paper develops a quantitative method using dSTORM microscopy to analyze γH2AX focus morphology during DNA repair, revealing chromatin structure and nucleosome organization around DNA breaks.

bioRxiv · May 14, 2019 · PreprintCell Biology